See Knowledge@Wharton‘s article on Daniel Zweidler’s (Mack Center Senior Fellow) case for how pharmaceutical companies could benefit by sharing their failures as well as their successes, in order to make research and development more efficient and improve the pharmaceutical pipeline. Why Sharing Failures Can Speed Up Innovation When it comes to innovation, most…Read More